Biotron Ltd (ASX: BIT) Share Price and News

Price

$0.0025

Movement

0.00 (0.0)

as at 23 May - Closed (20 mins delayed)

52 Week Range

$0.002 - $0.066

 
1 Year Return

-95.28%

Biotron Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04
$0.00
$0.02
$0.04

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $3.32 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.33 billion
Earnings per share -0.001
Dividend per share N/A
Year To Date Return -84.13%
Earnings Yield N/A
Franking -
Share Price

$0.0025

Day Change

0.00 (0.0)

52 Week Range

$0.002 - $0.066

Yesterday's Close

$0.0025

Today's Open

$0.0025

Days Range

$0.0025 - $0.0025

Volume

125,000

Avg. Volume (1 month)

711,361

Turnover

$313

as at 23 May - Closed

Biotron Ltd (ASX: BIT)
Latest News

a woman
Share Market News

ALL ORDINARIES finishes higher Thursday: 8 ASX shares you missed

The S&P/ASX 200 (Index:^AXJO)(ASX:XJO) and ALL ORDINARIES (Index:^AXAO) (ASX:XAO) ended up on Thursday, here are 8 ASX shares you missed.

Read more »

a woman
Share Gainers

Why Biotron, Magellan, Nick Scali, & Pinnacle shares are surging higher

The Magellan Financial Group Ltd (ASX:MFG) share price and the Nick Scali Limited (ASX:NCK) share price are two of four…

Read more »

a woman
Share Gainers

Biotron share price rockets higher on coronavirus testing news

The Biotron Limited (ASX:BIT) share price is rocketing higher on Thursday after announcing that it is testing its drugs against…

Read more »

a woman
Share Market News

These are the 10 best micro-cap shares over the past year

Is the Afterpay Touch Group Ltd (ASX: APT) of tomorrow on this list?

Read more »

a woman
Share Gainers

Why the Biotron share price surged 30% higher today

The Biotron Limited (ASX:BIT) share price surged as much as 30% higher on Friday. Here's why...

Read more »

a woman
Share Market News

HIV treatment hopeful Biotron reveals quarterly results

Biotron Limited (ASX:BIT) has a drug it claims could help treat HIV patients.

Read more »

a woman
Share Fallers

Why Aristocrat Leisure Limited is among 4 shares tumbling today

Bingo Industries Ltd (ASX:BIN) is also falling today as the ACCC knocks back its takeover offer for "Dial-a-Dump".

Read more »

a woman
Share Fallers

Why the Biotron Limited share price cratered today

Biotron Limited (ASX:BIT) is working on a treatment that could help cure HIV patients.

Read more »

a woman
Share Fallers

Why Coles Group Limited (ASX:COL) is among 4 shares rising today

The Biotron Limited (ASX:BIT) share price is flying as the company researches a cure for the HIV virus.

Read more »

a woman
Share Gainers

These small cap ASX shares are ending the week on a high

The Biotron Limited (ASX:BIT) share price is one of three at the small end of the market finishing the week…

Read more »

a woman
Share Gainers

These 3 small cap ASX shares are surging higher today

The Biotron Limited (ASX:BIT) share price is one of three surging higher at the small end of the market on…

Read more »

a woman
Share Gainers

These small cap ASX shares are on the rise on Monday

The Bubs Australia Ltd (ASX:BUB) share price is one of three at the small end of the market making a…

Read more »

BIT ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
23rd May 2025 2025-05-23T10:25:14 Biotron Investor WebinarYesNo10:25am1446k
2nd May 2025 2025-05-02T13:52:47 Company Secretary Appointment/ResignationYesNo1:52pm141k
24th Apr 2025 2025-04-24T09:07:48 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:07am7358k
10th Apr 2025 2025-04-10T10:15:34 Change of Director's Interest NoticeYesNo10:15am7276k
8th Apr 2025 2025-04-08T09:07:46 Application for quotation of securities - BITYesNo9:07am616k
8th Apr 2025 2025-04-08T09:06:51 Rights Issue ClosedYesNo9:06am2137k
18th Mar 2025 2025-03-18T11:34:16 Dispatch of Rights Issue Offer documentsYesNo11:34am2264k
13th Mar 2025 2025-03-13T09:32:45 Update on Rights Issue TimetableYesNo9:32am2165k
13th Mar 2025 2025-03-13T08:31:55 Update - Proposed issue of securities - BITYesNo8:31am621k
12th Mar 2025 2025-03-12T17:23:25 Replacement ProspectusYesNo5:23pm43395k

About Biotron Ltd

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

BIT Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
23 May 2025 $0.00 $0.00 0.00% 125,000 $0.00 $0.00 $0.00
22 May 2025 $0.00 $0.00 0.00% 565,000 $0.00 $0.00 $0.00
21 May 2025 $0.00 $0.00 0.00% 1,266,188 $0.00 $0.00 $0.00
20 May 2025 $0.00 $0.00 0.00% 920,250 $0.00 $0.00 $0.00
19 May 2025 $0.00 $0.00 0.00% 2,078,389 $0.00 $0.00 $0.00
16 May 2025 $0.00 $0.00 0.00% 201,727 $0.00 $0.00 $0.00
15 May 2025 $0.00 $0.00 0.00% 823,522 $0.00 $0.00 $0.00
14 May 2025 $0.00 $0.00 0.00% 63,780 $0.00 $0.00 $0.00
13 May 2025 $0.00 $0.00 0.00% 521,917 $0.00 $0.00 $0.00
12 May 2025 $0.00 $0.00 0.00% 857,727 $0.00 $0.00 $0.00
09 May 2025 $0.00 $0.00 0.00% 315,500 $0.00 $0.00 $0.00
08 May 2025 $0.00 $0.00 0.00% 60,045 $0.00 $0.00 $0.00
07 May 2025 $0.00 $0.00 0.00% 205,761 $0.00 $0.00 $0.00
06 May 2025 $0.00 $0.00 0.00% 418,979 $0.00 $0.00 $0.00
05 May 2025 $0.00 $0.00 0.00% 420,056 $0.00 $0.00 $0.00
02 May 2025 $0.00 $0.00 0.00% 3,405,849 $0.00 $0.00 $0.00
01 May 2025 $0.00 $0.00 0.00% 321,000 $0.00 $0.00 $0.00
30 Apr 2025 $0.00 $0.00 0.00% 458,025 $0.00 $0.00 $0.00
29 Apr 2025 $0.00 $0.00 0.00% 1,131,399 $0.00 $0.00 $0.00
28 Apr 2025 $0.00 $0.00 0.00% 341,722 $0.00 $0.00 $0.00

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
08 Apr 2025 Michael Hoy Issued 11,217,353 $33,652
Rights issue.
08 Apr 2025 Robert Thomas Issued 4,200,000 $12,600
Rights issue.
08 Apr 2025 Michelle Miller Issued 1,800,000 $5,400
Rights issue.
08 Apr 2025 Michelle Miller Issued 1,987,500 $5,962
Rights issue.
25 Nov 2024 Michael Hoy Expiry 934,780 $17,760
Options expired.
25 Nov 2024 Michelle Miller Expiry 315,000 $5,985
Options expired. As per announcement on 28-11-2024
25 Nov 2024 Robert Thomas Expiry 268,403 $5,099
Options expired.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Michael J Hoy Non-Executive DirectorNon-Executive Chairman Feb 2000
Mr Hoy has more than 30 years of corporate experience in Australia, the United Kingdom, USA and Asia. He is Chairman of Lipotek Pty Limited and a former director of John Fairfax Holdings Limited and FXF Trust.
Mr Robert Bain Thomas Non-Executive Director Mar 2012
Mr Thomas has over 35 years of experience in the securities industry, with Potter Partners (now UBS), County NatWest and Citigroup. He is the chairman of Starpharma Holdings Limited and a director of Clarity Pharmaceuticals Limited. He chairs Grahger Securities Pty Ltd and is a director of O'Connell Street Associates Pty Limited.
Dr Michelle Miller Managing Director Jun 2002
Dr Miller has worked for over 25 years in the bioscience industry, with experience in commercial drug development. Her experience includes several years at Johnson & Johnson developing anti-HIV gene therapeutics through preclinical research to clinical trials. She has finance industry experience from time spent as an Investment Manager with a specialist bioscience venture capital fund.
Mr Marcelo Mora Company Secretary May 2025
-
Marcelo Mora Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Rookharp Capital Pty Limited 26,920,201 2.98%
Jey Investment Pty Ltd 24,240,000 2.69%
Umbiram Pty Ltd <Michael Hoy Superfund A/C> 11,217,352 1.24%
Fordholm Investments Pty Ltd <Fordholm Super Fund A/C> 10,300,000 1.14%
Citicorp Nominees Pty Limited 10,201,698 1.13%
Dr Angela Fay Dulhunty 10,000,000 1.11%
Dr Huy Tran 9,699,357 1.07%
Dns Accounting And Law Consultancy Pty Ltd 8,359,582 0.93%
Attollo Copia Pty Ltd <F A Pires Super Fund A/C> 7,620,678 0.84%
Pathold No 222 Pty Ltd 7,600,000 0.84%
Armco Barriers Pty Ltd 7,550,000 0.84%
Mr William John Dunn 7,300,000 0.81%
Edstop Pty Limited <Superannuation Fund A/C> 6,045,906 0.67%
Standby Forty Six Pty Limited 5,600,000 0.62%
Vicex Holdings Proprietary Limited <Vicex Super A/C> 5,600,000 0.62%
Scotts A V Pty Ltd <Scotts Acorn Emp S/F A/C> 4,918,000 0.55%
Mr Travis Paul Gloury 4,819,355 0.53%
Mr Charles Tollios Panos 4,338,928 0.48%
Mr Peter James Nightingale 4,313,884 0.48%
Mr Mark Andrew Peterson 4,263,157 0.48%

Profile

since

Note